GHRP-2 Acetate | Research Use Only

What it is

GHRP-2, also known as pralmorelin, is a synthetic growth hormone-releasing peptide studied in research settings for its activity as a growth hormone secretagogue. Research literature describes it as a ghrelin receptor agonist that interacts with the growth hormone secretagogue receptor rather than acting through structural similarity to growth hormone-releasing hormone.

Origins and design rationale

GHRP-2 was developed as part of the growth hormone-releasing peptide class to study and enhance growth hormone secretagogue activity in experimental systems. Reviews of the GHRP family describe these peptides as synthetic, non-natural compounds created to stimulate somatotroph secretion through specific receptors at the pituitary and hypothalamic level, with GHRP-2 becoming one of the better-known compounds in this class.

Molecular profile

GHRP-2 is commonly described as a synthetic hexapeptide. PubChem lists growth hormone releasing hexapeptide with the molecular formula C46H56N12O6, and the literature consistently refers to GHRP-2 as a member of the hexapeptide growth hormone secretagogue family.

Scientific overview

In simplified terms, GHRP-2 is used in research to study growth hormone secretagogue receptor signaling, endocrine response patterns, and ghrelin-like receptor activity. Published work describes GHRP-2 as a synthetic agonist of ghrelin that has been extensively studied for growth hormone secretagogue activity, making it useful in receptor, endocrine, and signaling research models.

What researchers study with GHRP-2 Acetate

Key research focus areas often include
• Growth hormone secretagogue receptor signaling
• Ghrelin-agonist pharmacology in vitro and in vivo
• Endocrine response modeling involving GH release
• Comparative studies of synthetic GHRPs and related analogs

Regulatory and compliance notice

Research Use Only. Not for human or veterinary use. This description is provided for scientific context and must not be used to market GHRP-2 Acetate for diagnosis, cure, mitigation, treatment, or prevention of disease.

Citations and references

PubChem compound entry for growth hormone releasing hexapeptide, includes molecular formula and compound information.

Pralmorelin: GHRP-2, GPA 748, growth hormone-releasing peptide-2, review describing its diagnostic and growth hormone secretagogue context.

Laferrère et al. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men, describing GHRP-2 as a synthetic agonist of ghrelin and GH secretagogue.

Ghigo et al. Growth hormone-releasing peptides, review covering synthetic GHRPs, receptor activity, and endocrine signaling.

Camanni et al. Growth hormone-releasing peptides and their analogs, review summarizing receptor mechanisms and pharmacologic development of GHRPs.